Clinical Trial Update: Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease [Phase 2]

View source ↗

Summary

Phase 2 study evaluating hydroxyurea plus magnesium pidolate in people with Hemoglobin SC disease (sickle cell disease) was terminated, with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemoglobin Sc Disease
• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)
• Magnesium pidolate (magnesium pidolate)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Hemoglobin SC Disease | Phase 2 | Status: TERMINATED | Results posted: 2010-05-11